Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Medicare Advantage Billing Probe
  • School Vaccine Mandates
  • Weight Loss Drugs Coverage
  • Opioid Settlement Money
  • Abortion Pill Access

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, Oct 17 2018

Full Issue

The Five Companies Responsible For More Than Half Of Drug Ads On TV Would Bear Brunt Of Trump's Proposal

Stat takes a look at what those five drugmakers are spending on ads right now and how they might be impacted by the Trump administration's proposal to require prices to be included. Meanwhile, some families who have struggled with high drug costs are frustrated that the plan might not actually lower prices.

Stat: Five Drug Makers Will Be Hit Hardest By Trump’s New Proposal On Drug Ads 

President Trump wants to force drug companies to disclose their prices in TV ads — and that’s going to hit five companies much harder than any others: Pfizer, AbbVie, Eli Lilly, Amgen, and Allergan. Just a few dozen drug companies run any TV ads at all, and those five companies alone were responsible for more than half of the drug ads customers saw on TV in the last 12 months, according to a STAT analysis of data provided by analytics company iSpot.tv. Pfizer, for example, ran 37 unique ads in the last 12 months — racking up an advertising bill of over $600 million, according to iSpot’s estimate. (Florko, 10/17)

Bloomberg: J&J Says Putting Drug Prices In Ads May Scare Away Patients 

Johnson & Johnson, the world’s most valuable health-care company, says U.S. patients may avoid buying their medications if they see the prices in television ads. A proposal from the Trump administration forcing drugmakers to disclose the list price of any medication that costs more than $35 could discourage some from seeking treatment, executives from Johnson & Johnson said on an earnings conference call Tuesday. (Hopkins, 10/16)

The Hill: Trump Officials Ratchet Up Drug Pricing Fight

The Trump administration is ratcheting up its fight with the drug industry, with a new proposal that would force drugmakers to disclose their prices in television advertising. For months, officials have beat the drum over high drug prices but offered only minor tweaks to address the issue. With the latest proposal, which the industry is vowing to defeat, both sides are heading for a fierce clash. (Weixel, 10/17)

CBS News: Families Say Disclosing Drug Prices In TV Ads Not Enough

Five-year-old Elijah needs a drug with a big price tag: nearly $300,000 per year. Living with a life-threatening condition, Elijah was just three when he landed in the hospital after his family couldn't – and their insurance company wouldn't – cover the cost of a key drug, reports CBS News correspondent Chip Reid. "He was screaming 'Mommy why am I here?' Mommy, please take me home," his mother, Juliana Keeping, recalled. "People are cutting their pills in half, they are going without food, they are being hospitalized, and they are even dying because they can't afford prescription drugs. That happened to us and it's happening all over the country." (10/16)

Introducing 'Pharma Cash To Congress': Search and explore KHN's new tool that lets you discover which lawmakers rake in the most money (or the least) and which pharma companies are the biggest contributors.

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Wednesday, July 1
  • Tuesday, June 30
  • Monday, June 29
  • Friday, June 26
  • Thursday, June 25
  • Wednesday, June 24
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF